SOP MEDC

VCU Blogs

Dr. Martin Safo, named PI on an R61 grant from NIH, “Targeted Identification of Dual Acting Antisickling Agents for Sickle Cell Disease Therapy,” totaling $575,593.

Leave a Reply

Your email address will not be published. Required fields are marked *